Tumors of the Urinary and Male Genital Tract

The Oakstone Institute Clinical Update

Review topics in urinary tract and male genital pathology with this convenient program.

If your primary viewing mode will be on a computer or tablet, we recommend the Online Video package. In addition to online access, you will receive a USB with MP4 files. Use the USB to watch offline or import into iTunes and other media players and then synch to your mobile device, laptop or desktop. Plus you save $130 including standard shipping charges vs the DVD package.

    Video
895.0000
SKU: 991

Gain New Insight

With this course, you’ll develop insights on the classifications, identification of new entities, use of immunohistochemistry, and molecular biology techniques within urinary tract and male genital pathology. Tumors of the Urinary and Male Genital Tract features lectures on the most important aspects of pathology of the kidneys, urinary bladder, prostate, penis, testis, and paratesticular structures.

The program is directed by Ivan Damjanov, MD, PhD, of The University of Kansas School of Medicine; he and his distinguished faculty emphasize current recommendations regarding urologic tumors.

This course, ideal for hospital and laboratory-based diagnostic pathologists, urologists and urology residents, medical oncologists, and oncology fellows, will improve your ability to:

  • Discuss the most recent histopathological classification of renal tumors, emphasizing the latest WHO and ISUP recommendations
  • Recognize the subtypes of urinary bladder and penile carcinomas, and the importance of pathologic diagnosis for clinical prognosis and therapy
  • Describe the variant forms of prostatic carcinoma and provide a practical algorithm for diagnoses

Learn at Your Convenience

As with other Oakstone programs, Tumors of the Urinary and Male Genital Tract offers an ideal way to fulfill CME requirements in a format that fits easily into your busy schedule. The program is available in online and DVD video formats, which means you can access it whenever you have free time and computer/DVD access.

With Tumors of the Urinary and Male Genital Tract, you can earn up to 11 AMA PRA Category 1 Credits while enhancing your clinical practice – all from the comfort of your home or office.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

  • Inflammatory and Pseudoneoplastic Lesions of the Urinary System - Liang Cheng, MD
  • Mesenchymal and Other Uncommon Tumors of the Urinary Bladder - Liang Cheng, MD
  • Urothelial Carcinoma and its Variants - Liang Cheng, MD
  • Carcinoma of the Penis – Advances and New Developments - Antonio L. Cubilla, MD
  • Carcinoma of the Penis – Basic Aspects - Antonio L. Cubilla, MD
  • Germ Cell Tumors of the Testis - Ivan Damjanov, MD, PhD
  • Testicular Tumors II - Ivan Damjanov, MD, PhD
  • Urinary Cytopathology - Fang Fan, MD
  • Adult Kidney Tumors – ISUP Vancouver 2012 Classification New Entities - Ondřej Hes, MD, PhD
  • Adult Renal Tumors – WHO 2004 Classification - Ondřej Hes, MD, PhD
  • Uncommon Renal Tumors, Newly Described Renal Neoplasms, and Pitfalls - Ondřej Hes, MD, PhD
  • Carcinoma of the Prostate - Peter A. Humphrey, MD
  • Uncommon Histopathologic Subtypes of Prostate Cancer - Peter A. Humphrey, MD

Program/Course Director

Ivan Damjanov, MD, PhD

  • Professor of Pathology
  • Department of Pathology
  • The University of Kansas School of Medicine

Speakers

Liang Cheng, MD

  • Professor of Pathology and Urology
  • Director of Molecular Pathology Laboratory
  • Chief of Genitourinary Pathology Division
  • Director, Fellowship in Urologic Pathology
  • Indiana University School of Medicine

Antonio L. Cubilla, MD

  • Professor of Pathology
  • Instituto de Patologia e Investigacion
  • Brizuela 325
  • Asuncion, Paraguay

Fang Fan, MD

  • Barabara F. Atkinson Professor of Pathology
  • Department of Pathology
  • The University of Kansas School of Medicine

Accreditation Statement

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation

Oakstone Publishing, LLC designates this enduring material for a maximum of 11 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: April 1, 2014
Date Credits Expire: April 1, 2017
Estimated Time to Complete: 11 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

Learning Objectives

Upon completion of this activity, the participant will be able:

  • Discuss the most recent  histopathological classification of renal tumors, with special emphasis on the latest recommendations of the experts of WHO and ISUP. A correlation will be made between the histopathology and the response of these tumors to therapy
  • Recognize the subtypes of urinary bladder and penile  carcinomas, and the importance of pathologic diagnosis for the clinical prognosis and therapy of these tumors
  • Describe the variant forms of prostatic carcinoma and provide a practical algorithm to diagnosing them. The differential diagnosis of various histologic subtypes of prostatic carcinoma will be illustrated and supplemented with practice tested advices
  • Describe the most common forms of testicular cancer and to illustrate the difficulties one might face in correctly diagnosing them. Special emphasis will be on morphological changes seen in treated testicular cancers and their metastases

CME credit is awarded upon successful completion of a course evaluation and post-test.

Intended Audience

  • Hospital - and Laboratory-Based Diagnostic Pathologists, Academic Pathologists and Pathology Residents
  • Urologists and Urology Residents
  • Medical Oncologists and Oncology Fellows

oakstone is a division of ebix

Ebix is a leading international supplier of On-Demand software and E-commerce to the insurance, financial and health care industries. A.D.A.M. is a business unit of Ebix focused on providing innovative multimedia health content trusted by best-in-class websites, consumer health portals, health care, biomedical device, pharmaceutical, and academic organizations.